| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 27.54% | RBC Capital | $17 → $16 | Maintains | Outperform |
| 04/28/2023 | 35.51% | Credit Suisse | $14 → $17 | Maintains | Neutral |
| 04/27/2023 | 35.51% | RBC Capital | → $17 | Reiterates | → Outperform |
| 03/24/2023 | 11.6% | Jefferies | $8.5 → $14 | Upgrades | Underperform → Hold |
| 02/21/2023 | 43.48% | Benchmark | → $18 | Reiterates | → Buy |
| 02/17/2023 | 11.6% | Credit Suisse | $12 → $14 | Maintains | Neutral |
| 02/17/2023 | 35.51% | RBC Capital | $14 → $17 | Upgrades | Sector Perform → Outperform |
| 02/13/2023 | 43.48% | Benchmark | → $18 | Reiterates | → Buy |
| 10/20/2022 | 43.48% | Benchmark | → $18 | Upgrades | Hold → Buy |
| 10/20/2022 | -4.34% | Credit Suisse | $15 → $12 | Maintains | Neutral |
| 10/20/2022 | 11.6% | RBC Capital | $17 → $14 | Maintains | Sector Perform |
| 04/21/2022 | 43.48% | Credit Suisse | $17 → $18 | Maintains | Neutral |
| 04/21/2022 | 59.43% | RBC Capital | $17 → $20 | Maintains | Sector Perform |
| 02/10/2022 | 7.61% | Jefferies | $19 → $13.5 | Downgrades | Hold → Underperform |
| 10/22/2021 | 75.37% | Credit Suisse | $28 → $22 | Maintains | Neutral |
| 10/21/2021 | 59.43% | RBC Capital | $29 → $20 | Maintains | Sector Perform |
| 10/20/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 07/22/2021 | 131.17% | RBC Capital | $30 → $29 | Maintains | Sector Perform |
| 02/11/2021 | 147.11% | Credit Suisse | $32 → $31 | Maintains | Neutral |
| 10/22/2020 | 107.25% | Credit Suisse | $31 → $26 | Maintains | Neutral |
| 07/23/2020 | 131.17% | Baird | → $29 | Downgrades | Outperform → Neutral |
| 07/07/2020 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 07/06/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 04/22/2020 | 115.23% | Credit Suisse | $32 → $27 | Maintains | Outperform |
| 04/22/2020 | 67.4% | RBC Capital | $26 → $21 | Maintains | Sector Perform |
| 04/20/2020 | 123.2% | Baird | → $28 | Upgrades | Neutral → Outperform |
| 11/22/2019 | 107.25% | RBC Capital | → $26 | Initiates Coverage On | → Sector Perform |
| 10/23/2019 | 171.02% | Benchmark | $37 → $34 | Reiterates | → Buy |
| 07/24/2019 | 242.77% | Sidoti & Co. | $51 → $43 | Maintains | Buy |
| 07/24/2019 | 179% | Credit Suisse | $41 → $35 | Maintains | Outperform |
| 07/12/2019 | 155.08% | Jefferies | $40 → $32 | Downgrades | Buy → Hold |
| 05/01/2019 | 139.14% | Stifel | $33 → $30 | Maintains | Sell |
What is the target price for Healthcare Services Group (HCSG)?
The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by RBC Capital on July 27, 2023. The analyst firm set a price target for $16.00 expecting HCSG to rise to within 12 months (a possible 27.54% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthcare Services Group (HCSG)?
The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by RBC Capital, and Healthcare Services Group maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
Is the Analyst Rating Healthcare Services Group (HCSG) correct?
While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a maintained with a price target of $17.00 to $16.00. The current price Healthcare Services Group (HCSG) is trading at is $12.55, which is out of the analyst's predicted range.